================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report: October 19, 2006
Date of earliest event reported: October 19, 2006
PFIZER INC.
(Exact name of registrant as specified in its charter)
Delaware 1-3619 13-5315170
(State or other jurisdiction (Commission (I.R.S. Employer
of incorporation) File Number) Identification No.)
235 East 42nd Street
New York, New York 10017
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code:
(212) 573-2323
Not Applicable
(Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[ ] Written communication pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2 (b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
Item 2.02 Results of Operations and Financial Condition
On October 19, 2006, Pfizer Inc. ("Pfizer") issued a press release announcing
its financial results for the third quarter of 2006. The information contained
in the press release is deemed to be "filed" under the Securities Exchange Act
of 1934 as Exhibit 99 to this report, and such press release is incorporated
herein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit 99 - Press Release of Pfizer Inc. dated
October 19, 2006, reporting Pfizer's financial results for the
third quarter of 2006. Exhibit 99 is deemed to be "filed" under
the Securities Exchange Act of 1934 in this Current Report on
Form 8-K.
SIGNATURE
Under the requirements of the Securities Exchange Act of 1934, the registrant
has caused this report to be signed on its behalf by the authorized undersigned.
PFIZER INC.
By: /S/ Margaret M. Foran
-------------------------------
Name: Margaret M. Foran
Title: Senior Vice President-Corporate
Governance, Associate General
Counsel and Corporate Secretary
Dated: October 19, 2006
EXHIBIT INDEX
Exhibit No. Description
----------- -----------------------------------------------------------------
99 Press Release of Pfizer Inc. dated October 19, 2006, reporting
Pfizer's financial results for the third quarter of 2006.